Abiopharma

🔍 YUSKO MARK W (Director)

Company: Nakamoto Inc. (NAKA)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Sold 10,623 shares of Common Stock (Direct)
  Date: 2026-08-21 | Code: A | equity_swap_involved: 0 | shares_owned_after: 13,442.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Reflects restricted stock units ("RSUs") that shall time-vest in full on the one-year anniversary of August 14, 2026 (the "Vesting Date"), subject to the RSU award agreement and the Reporting Person's continued service on the board of directors of Nakamoto Inc. (the "Issuer") through the Vesting Date.
• F2: Effective May 22, 2026, the Issuer effected a 1-for-40 reverse stock split of the Issuer's common stock, par value $0.001 per share. The number of securities reported herein has been adjusted to reflect the reverse stock split.